
Nolatrexed
CAS No. 147149-76-6
Nolatrexed( —— )
Catalog No. M17316 CAS No. 147149-76-6
Nolatrexed is a thymidylate synthase inhibitor with potential anticancer activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 41 | Get Quote |
![]() ![]() |
5MG | 75 | Get Quote |
![]() ![]() |
10MG | 136 | Get Quote |
![]() ![]() |
25MG | 227 | Get Quote |
![]() ![]() |
50MG | 408 | Get Quote |
![]() ![]() |
100MG | 600 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNolatrexed
-
NoteResearch use only, not for human use.
-
Brief DescriptionNolatrexed is a thymidylate synthase inhibitor with potential anticancer activity.
-
DescriptionNolatrexed is a thymidylate synthase inhibitor with potential anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetLipase
-
RecptorThymidylate synthase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number147149-76-6
-
Formula Weight284.33
-
Molecular FormulaC14H12N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1c(c2c(cc1)[nH]c(nc2=O)N)Sc1ccncc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1: Zheng J, et al. Metastatic nasopharyngeal carcinoma outcomes in patients on cisplatin with nolatrexed or 5-fluorouracil. Oncol Res Treat. 2014;37(10):540-4. doi: 10.1159/000368107. Epub 2014 Sep 16. PubMed PMID: 25342504.
molnova catalog



related products
-
Atglistatin
Atglistatin is a highly potent, selective and competitive inhibitor of adipose triglyceride lipase (ATGL) with an?IC50?of ~0.7 μM for inhibition of lipolysis in vitro, but no toxicity up to a concentration of 50 μM.
-
Cravatt Reagent
Cravatt Reagent is a potent and selective MAGL inhibitor. Cravatt Reagent inhibits MAGL (IC50 = 9.1 nM). MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
-
Lalistat 2
Lalistat 2 is a selective inhibitor of lysosomal acid lipase with IC50 of 152 nM and exhibits no inhibition of human pancreatic lipase or bovine milk lipoprotein lipase (up to 10 μM).